|
JSM Activity #345This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions. To View the Program: You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time. |
|
|
Legend: = Applied Session,
= Theme Session,
= Presenter |
345 | Wed, 8/10/05, 8:30 AM - 10:20 AM | MCC-200 G |
Proof of Concept Strategies: Aspects of Study Design and Analysis - Invited - Papers | ||
Biopharmaceutical Section, Section on Physical and Engineering Sciences, WNAR | ||
Organizer(s): Michael Branson, Novartis Pharmaceuticals | ||
Chair(s): Michael Branson, Novartis Pharmaceuticals | ||
8:35 AM | Decisions in a Proof of Concept Strategy: A union between Pharmacology and Statistics — Amy Racine, Novartis Pharmaceuticals AG | |
9:00 AM | Adaptive Designs for Proof of Concept and Dose Finding Trials — Michael Smith, Pfizer, Ltd. | |
9:24 AM | Role of Mechanistically-based PK/PD Models in Drug Development: A Case Study — Niclas Jonsson, Uppsala University | |
9:50 AM | Disc: Donald A. Berry, The University of Texas M. D. Anderson Cancer Center | |
10:10 AM | Floor Discussion | |
JSM 2005
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |